"Of Mice and Measures": A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic
(2018)
Journal Article
Gordish-Dressman, H., Willmann, R., Dalle Pazze, L., Kreibich, A., van Putten, M., Heydemann, A., Bogdanik, L., Davies, K., Demonbruen, A., Duan, D., Elsey, D., Fukada, S., Girgenrath, S., Gonzalez, P., Grounds, M., Nichols, A., Partridge, T., Passini, M., Sanarica, F., Schnell, F., …Aartsma-Rus, A. (2018). "Of Mice and Measures": A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic. Journal of Neuromuscular Diseases, 5(4), 407-414. https://doi.org/10.3233/JND-180324
A new line of dystrophic mdx mice on the DBA/2J (D2) background has emerged as a candidate to study the efficacy of therapeutic approaches for Duchenne muscular dystrophy (DMD). These mice harbor genetic polymorphisms that appear to increase the seve... Read More about "Of Mice and Measures": A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic.